First Time Loading...
A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 16 400 KRW 4.66%
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
AprilBio Co Ltd

Wall Street analysts forecast AprilBio Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 27 540 KRW with a low forecast of 24 240 KRW and a high forecast of 31 500 KRW.

Lowest Forecast
Wall Street Target
24 240 KRW
48% Upside
Average Forecast
Wall Street Target
27 540 KRW
68% Upside
Highest Forecast
Wall Street Target
31 500 KRW
92% Upside
Lowest
Price Target
24 240 KRW
48% Upside
Average
Price Target
27 540 KRW
68% Upside
Highest
Price Target
31 500 KRW
92% Upside
AprilBio Co Ltd Competitors:
Price Targets
DTIL
Precision BioSciences Inc
218% Upside
B
BAVA
Bavarian Nordic A/S
69% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
34% Upside
BCYC
Bicycle Therapeutics PLC
91% Upside
DTIL
Precision BioSciences Inc
218% Upside
B
BAVA
Bavarian Nordic A/S
69% Upside
X
688278
Xiamen Amoytop Biotech Co Ltd
34% Upside
BCYC
Bicycle Therapeutics PLC
91% Upside
NTLA
Intellia Therapeutics Inc
203% Upside
CDMO
Avid Bioservices Inc
46% Upside
REGN
Regeneron Pharmaceuticals Inc
11% Upside
TGTX
TG Therapeutics Inc
81% Upside

Revenue
Forecast

Revenue Estimate
AprilBio Co Ltd

Revenue forecast
is not available for
AprilBio Co Ltd

Operating Income
Forecast

Operating Income Estimate
AprilBio Co Ltd

Operating Income forecast
is not available for
AprilBio Co Ltd

Net Income
Forecast

Net Income Estimate
AprilBio Co Ltd

Net Income forecast
is not available for
AprilBio Co Ltd

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AprilBio Co Ltd's stock price target?
Price Target
27 540 KRW

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 27 540 KRW with a low forecast of 24 240 KRW and a high forecast of 31 500 KRW.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.